K213858: LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K213858 (LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus, cleared 2022-07-26 for DiaSorin, Inc.) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K213858 |
| Cleared Device Trade / Generic Name | LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus |
| FDA Applicant on Filing | DiaSorin, Inc. |
| FDA 3-Letter Product Classification | Product Code NXO |
| FDA Substantial Equivalence Decision Date | 2022-07-26 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at DiaSorin, Inc., compare peer devices under FDA Product Code NXO, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.